Hospitals want to stop giving fluoroquinolones to prevent dangerous Clostridioides difficile infections. These drugs can cause severe gut issues. But getting the right plan to work is hard. A review looked at how four different hospital sites tried to put new rules in place. They planned 330 changes to their approach. Most of these changes were planned ahead of time. Only 157 changes happened unexpectedly. This shows that sticking to a plan is difficult in real life. Rural and community hospitals needed more unexpected adjustments than big academic centers. Sites that had tried similar rules before did better. They had fewer surprises when implementing the new safety measures. The review also noted that how hospitals pick their strategies matters. One size does not fit all. Each hospital has unique needs. The study found that context-specific choices are vital. Without them, standard plans fail. This review highlights the gap between theory and practice. Real-world rollout is messy. It requires careful attention to local differences.
Review of Fluoroquinolone Restriction Implementation Modifications for C. difficile PreventionHospital plans to stop risky drugs often changed during real-world rollout
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This review examines implementation strategy modifications from the Fluoroquinolone Restriction for the Prevention of Clostridioides difficile infection (FIRST) trial across four diverse hospital sites (academic, rural, community). The analysis focuses on planned versus unplanned modifications, modification intensity and type, and differences by hospital type and prior experience.
Key findings show that planned modifications outnumbered unplanned modifications (72% planned vs 34% unplanned), with 330 planned and 157 unplanned modifications reported over two years. Rural and community hospitals required more unplanned modifications than academic centers (average 41 vs 31). Sites with prior restrictive intervention experience had higher planned-to-unplanned ratios (3.1:1 vs 1.6:1).
The authors note that context-specific selection and modification of implementation strategies remain underreported, limiting generalizability. The findings are observational and based on four diverse sites, so causality should not be inferred.
For practice, standardized implementation approaches inadequately address critical organizational differences. Clinicians and administrators should consider context-sensitive strategy selection and intensity calibration when implementing fluoroquinolone restriction to prevent C. difficile infection.